Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $346.62 | 6 | 96.7% |
| Education | $12.01 | 1 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vertos Medical, Inc. | $276.26 | 2 | $0 (2024) |
| Medtronic, Inc. | $49.76 | 2 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $12.20 | 1 | $0 (2022) |
| UroGen Pharma, Inc. | $12.01 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $284.66 | 3 | Vertos Medical, Inc. ($276.26) |
| 2023 | $22.65 | 1 | Medtronic, Inc. ($22.65) |
| 2022 | $51.32 | 3 | Medtronic, Inc. ($27.11) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/02/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $8.40 | General |
| Category: Sleep Apnea testing | ||||||
| 03/05/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $138.13 | General |
| Category: Orthopedic | ||||||
| 03/05/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $138.13 | General |
| Category: Orthopedic | ||||||
| 05/21/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/20/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/22/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Education | In-kind items and services | $12.01 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 915 | 1,287 | $436,412 | $80,772 |
| 2022 | 23 | 875 | 1,117 | $285,567 | $62,203 |
| 2021 | 24 | 901 | 1,130 | $243,890 | $57,843 |
| 2020 | 13 | 276 | 307 | $62,204 | $11,375 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 141 | $69,580 | $12,439 | 17.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $52,081 | $11,102 | 21.3% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 25 | 78 | $43,914 | $8,384 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 129 | $50,864 | $7,800 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $30,891 | $6,173 | 20.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 37 | 39 | $14,781 | $5,295 | 35.8% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 18 | 18 | $23,418 | $4,845 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 31 | $14,516 | $4,003 | 27.6% |
| 51705 | Simple change of bladder tube | Office | 2023 | 14 | 44 | $13,979 | $2,977 | 21.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 21 | 69 | $16,626 | $2,920 | 17.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 17 | 17 | $9,129 | $2,546 | 27.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 17 | 17 | $9,129 | $2,400 | 26.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 17 | 17 | $7,565 | $1,607 | 21.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 153 | 199 | $11,859 | $1,436 | 12.1% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 16 | 24 | $6,996 | $1,306 | 18.7% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 11 | 12 | $2,236 | $1,261 | 56.4% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 21 | 28 | $27,447 | $1,240 | 4.5% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 63 | 78 | $5,460 | $719.33 | 13.2% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 17 | 17 | $6,086 | $703.15 | 11.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 66 | $5,683 | $697.62 | 12.3% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 17 | 17 | $5,134 | $410.55 | 8.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 11 | 11 | $1,067 | $251.78 | 23.6% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 19 | 21 | $2,667 | $159.01 | 6.0% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 14 | 35 | $1,258 | $78.25 | 6.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 36 | 43 | $4,048 | $17.59 | 0.4% |
About Dr. Christopher Hoover, M.D
Dr. Christopher Hoover, M.D is a Urology healthcare provider based in Gallup, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982925673.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Hoover, M.D has received a total of $358.63 in payments from pharmaceutical and medical device companies, with $284.66 received in 2024. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($346.62).
As a Medicare-enrolled provider, Hoover has provided services to 2,967 Medicare beneficiaries, totaling 3,841 services with total Medicare billing of $212,193. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Gallup, NM
- Active Since 06/16/2010
- Last Updated 07/02/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1982925673
Products in Payments
- mild Device Kit (Device) $276.26
- INTERSTIM (Device) $27.11
- INTELLIS ADAPTIVESTIM (Device) $22.65
- Nubeqa (Drug) $12.20
- JELMYTO (Drug) $12.01
- WatchPATONE (Device) $8.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.